William R. Huckle, Editor
|
September 9-12, 2020
Conrad Hotel Seoul
|
Boston, MA
July 7-9, 2020
|
Vascular Biology 2020
Newport, RI
October 25-29, 2020
|
Shop at Amazon?
Help Support NAVBO
|
|
|
NAVBO Trainees in the Spotlight
|
Giving Tuesday - December 3
|
Please Consider Donating to NAVBO
Your donation will benefit NAVBO educational activities and awards for trainees, including scholarships to Vasculata. (For those in the US, NAVBO is a 501(c)3 charitable organization; your contribution is tax deductible).
Thank you for your support!
Why not share your enthusiasm for Vascular Biology with colleagues and staff. Purchase a NAVBO t-shirt and save 20% through December 4 - use promo code HOLIDAY20 to get your 20% off.
Go to https://teespring.com/vascular-biology-t-shirt to purchase items.
|
Travel Awards Available for the Microcirculatory Society Annual Meeting
Any NAVBO Trainee member who submitted an abstract to the Microcirculatory Society Annual Meeting at Experimental Biology is eligible for a Travel Award.
See our web site for more details and to apply for the award -
|
Kristy Red-Horse will give next month's webinar
Our December 19 webinar at 1:00pm EST will feature
Kristy Red-Horse of Stanford University. Her presentation is titled, "
Coronary blood vessels play multiple roles in cardiac development."
And Mark Your Calendar
The first webinar in 2020 will feature
Mark Kahn, University of Pennsylvania, and his talk on
"The Gut-Brain Axis in Cerebral Cavernous Malformation." Plan to join us on January 24 at 1:00pm EST. A link to the registration and web page will be available in our next NewsBEAT.
NAVBO Webinars are free to current NAVBO Members. Non-members can attend for $25 per webinar.
And don't forget you can watch archived webinars as well - go to
|
Promote Your Presentation on the Web Site
|
Current NAVBO Members Can List Their Upcoming Presentations (Oral or Poster) on our Web Site
Keep members, and all who visit our web site, aware of presentations by NAVBO members. If you are attending the meeting, be sure to attend your NAVBO colleague's presentation. If you are also presenting at that meeting, you can attend each other's presentations and offer mutual support! It can also help make you aware when a colleague is in your town so you reach out and arrange an in-person chat. And finally, this listing can also keep you abreast of other relevant meetings and conferences.
There is a form at the bottom of the page for you to add your presentation.
|
Welcome to our Newest Member:
Homare Ito, University of Maryland Baltimore
|
Recent Publications by NAVBO Members
|
Mitochondrial thioredoxin-2 maintains HCN4 expression and prevents oxidative stress-mediated sick sinus syndrome Journal of Molecular and Cellular Cardiology
OBJECTIVE: Sick sinus syndrome (SSS) is associated with loss of HCN4 (hyperpolarization-activated cyclic nucleotide-gated potassium channel 4) function in the cardiac conduction system. The underlying mechanism for SSS remains elusive.
Read more
VEGF signalling enhances lesion burden in KRIT1 deficient mice Journal of Cellular and Molecular Medicine
The exact molecular mechanisms underlying CCM pathogenesis remain a complicated and controversial topic. Our previous work illustrated an important VEGF signalling loop in KRIT1 depleted endothelial cells.
Read more
|
Funding opportunity for early phase clinical trials will be funded through a partnership between the Alzheimer Association and the Gates Foundation
"PART THE CLOUD (PTC) Bioenergetics/ Mitochondria, Clearance Related, Vascular Contributions and Inflammation Clinical Trials Program" will accelerate the testing of innovative therapy, including experimental or repurposed drug and/or experimental or repurposed device in the earliest stages of neurodegeneration. For this program, therapeutic approaches to Alzheimer's disease (AD) and related dementias (ADRD) should have a focus on biological mechanisms related to vascular pathology, mitochondrial/ bioenergetics, clearance related mechanisms (autophagy, lysosomal and lymphatic/ glymphatic systems) and inflammation. Projects will be considered that move experimental or repurposed drug candidates and/or experimental or repurposed trial ready devices into Phase 1 or Phase 2 clinical trials for AD and/or ADRD.
Please see all the RFA details at this link:
|
Partner Network Advantage on the NAVBO Job Board
|
Why post your job on NAVBO's career center rather than going directly to the larger job networks?
Pricing on the mass job boards can vary, but to get a job noticed you typically have to sponsor it for $5 - $10 per day, which can add up quickly especially since you also pay for each click the job gets. When you add it all together, you could be spending up to $45 per day on your job posting. But, when posting a job on NAVBO's career center, you simply pay a flat fee! The Premium package includes our Exclusive Extended Partner Network - which means the jobs are broadcast to sites like ZipRecruiter and Jobs2Careers and more for a flat fee.
With special member pricing, you can post a job for as low as $300 with this Partner Network. You never pay for each click, just the flat fee on the NAVBO career center. In addition, the Premium package includes a 60-day job posting making it a great value. The Premium packages also offer features like having your company's logo featured on the career center homepage, having your job appear first in search results, and more.
|
Your data privacy and security are important to NAVBO. To that end, we have updated our privacy policy to reflect recent privacy and security regulation implementations and changes.
Please review our policy as time permits so you have a complete understanding of the data we have, why we have it, and how we use it.
Part of the updates relate directly to the European Union's new General Data Protection Regulation (GDPR) that went into place May 25. The GDPR seeks to improve the transparency of data usage and give end users more control over their own data. We believe these changes are important and will be compliant with the GDPR regulations.
Contact NAVBO if you have any questions or to
change your communication preferences.
Please note, you can unsubscribe to this newsletter at anytime by clicking on the SafeUnsubscribe in the footer.
|
|
|